US-based medical device developer Apama Medical secured $11m of a planned $17.5m series B round on Tuesday from investors including Ascension Ventures, the corporate venturing arm of healthcare provider Ascension Health.
Venture capital firms Onset Ventures and Incept also participated alongside several unnamed angel investors.
Apama previously raised $3.2m from Broadview Ventures in a series A-1 round in 2013, but has not disclosed any additional details concerning series A funding. The company previously secured $1.1m in a 2010 seed round backed by angel investors.
Apama graduated from medical technology incubator Shifamed and is focused on the electrophysiology market. It has developed a catheter-based approach to treat atrial fibrillation, an abnormal heart rhythm which can cause fainting, palpitations, chest pain or heart failure.